Guanfacine-Associated Anxiety in a Child Diagnosed With DMDD and ADHD: A Case Presentation
Oxcarbazepine-Induced Dizziness-A Rare Presentation of Drug Misuse: A Case Report
Adverse Reactions to Clozapine: Plasma Clozapine in Relation to Smoking Status
In treatment-refractory schizophrenia, pre-dose plasma clozapine concentrations are, on average, lower in smokers than in nonsmokers. This may relate to the incidence of adverse drug reactions (ADR).
Effects of Coenzyme Q10 Supplementation on Depressive Symptoms and Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Coenzyme Q10 (CoQ10) is a mitochondrial cofactor with antioxidant and anti-inflammatory properties that may counteract mechanisms implicated in depression, such as oxidative stress and mitochondrial dysfunction. We evaluated the efficacy of CoQ10 supplementation on depressive symptoms and fatigue in patients with depression, whether as a primary disorder or in the context of underlying medical illness.
Myoclonic Movements and Catatonic-Like Symptoms After Abrupt Cessation of Clozapine: A Case Report and Discussion
Betamethasone-Associated Psychosis in a Pregnant Woman Diagnosed With Schizophrenia
Avoidant/Restrictive Food Intake Disorder Inappetence Subtype, Precipitated by SARS-CoV-2 Olfactory and Gustatory Impairment, Treated Successfully With Methylphenidate: A Case Report
Use of Esketamine NS in Treatment-Resistant Depression/Gambling Disorder Comorbidity: A Case Report
The Synergistic Effect of Bupropion-Dextromethorphan With Thyroid Supplementation in Treatment-Resistant Depression: A Case Report
Factors Predicting the Efficacy of Valbenazine and Exacerbation of Tardive Dyskinesia After Valbenazine Discontinuation in Japanese Patients: A Post Hoc Analysis of the J-KINECT Study
To identify factors affecting valbenazine efficacy and change in tardive dyskinesia (TD) symptoms after valbenazine discontinuation using post hoc analysis of the J-KINECT study evaluating valbenazine efficacy and safety in patients with TD.
Fluvoxamine Augmentation of Clozapine and Dose-dependent Interaction Patterns: A Case Report
Antibiomania: A Systematic Review of Clarithromycin-Associated Manic Episodes
Antibiomania, a rare adverse reaction, refers to antibiotic-induced mania, with clarithromycin most frequently implicated. Symptoms include mood elevation, hyperactivity, and hallucinations, typically resolving after discontinuation of the drug. This review examines reported cases to better characterize clinical patterns and guide clinical recognition and management.
Question: Does Cinnamon Interfere With Antidepressant Metabolism?
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings
Tobacco use poses a large public health problem, particularly among those with mental illness, but behavioral health providers often do not prioritize management of this disorder.
Efficacy of Intravenous Racemic Ketamine on Global Severity and Individual Symptoms of Depression: An Exploratory Retrospective Analysis
This study aims to assess the effects of intravenous racemic ketamine on global depression severity and individual depressive symptoms in patients with treatment-resistant depression.
Major Limitations of Randomized Controlled Trials Assessing Antidepressant Efficacy
Diet Drug Interactions: Achieving and Maintaining Ketosis As Adjunct to Psychotropic Polypharmacotherapy
Persistent Hiccups Associated With Long-Acting Injectable Aripiprazole in a Man With Schizophrenia
Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review
Lithium is a mainstay treatment for bipolar disorder, but its narrow therapeutic index and susceptibility to pharmacokinetic interactions make appropriate monitoring crucial. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide, are increasingly prescribed for type 2 diabetes and weight management. Scarce evidence exists on the potential interaction between semaglutide and lithium.
Fatal Outcomes in Use of Clozapine: A VigiBase Study of 6402 Women and 11,222 Men
In 1975, US clozapine studies stopped after pharmacovigilance identified 8 Finnish fatal outcomes during agranulocytosis. In 1989, clozapine was approved with hematological monitoring for treatment-resistant schizophrenia. This study focuses on over/underrepresented fatal outcomes in female versus male adults on clozapine.
